Special Considerations in the Management of Women With HIV, Including Management of Conception and Pregnancy
Summary
- Antiretroviral-associated adverse events are more frequent in women than men[Prins 2005; Molina 2010; Mills 2009; Brinkman 1999; Bersoff-Matcha 2001; Mazhude 2002; Sanne 2005] and women may be more likely to modify or discontinue ART because of adverse events[Lucas 1999]
- Initiation of a nevirapine-containing regimen should be avoided in women with a CD4+ cell count > 250 cells/mm3 due to increased risk for severe hepatotoxicity[Hitti 2004]
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content